Drug profile · INN
cipaglucosidase alfa
POMBILITI
cipaglucosidase alfa (POMBILITI) is a glycogen hydrolytic enzyme.
EMA: approved Alimentary tract and metabolism (A16) A16AB
Patents linked 0
Pipeline programs 2
News articles 1
Drug details — cipaglucosidase alfa
- Class
- Alimentary tract and metabolism (A16)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
cipaglucosidase alfa (POMBILITI) is a glycogen hydrolytic enzyme.
Key facts
INN cipaglucosidase alfa
Brand POMBILITI
Mechanism Glycogen hydrolytic enzyme
Target Glycogen
Therapeutic class Alimentary tract and metabolism (A16)
ATC code A16AB
Mechanism of action
Glycogen hydrolytic enzyme
Primary target: Glycogen
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Recent coverage
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cipaglucosidase alfa?
cipaglucosidase alfa (POMBILITI) is a glycogen hydrolytic enzyme.
What is the brand name for cipaglucosidase alfa?
POMBILITI is a marketed brand name for cipaglucosidase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.